KYONGBO PHARMACEUTICAL CO., LTD. Logo

KYONGBO PHARMACEUTICAL CO., LTD.

A pharmaceutical company specializing in APIs, finished drugs, and CDMO services.

214390 | KO

Overview

Corporate Details

ISIN(s):
KR7214390007
LEI:
Country:
South Korea
Address:
충청남도 아산시 실옥로 174, 아산시

Description

Kyongbo Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering integrated services from early-stage development through to commercial cGMP production. Its core product portfolio includes a diverse range of APIs, such as sterile and non-sterile cephalosporins, carbapenem antibiotics, and high-potency cytotoxic anti-cancer agents. In addition to APIs, the company manufactures finished dosage forms, including solid oral medications and sterile injectables. Kyongbo Pharmaceutical utilizes dedicated and segregated manufacturing facilities to produce its specialized product lines, supported by a strong commitment to research and innovation in API synthesis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-10 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.6 KB
2025-01-23 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.4 KB
2025-01-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2025-01-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2025-01-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2025-01-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2025-01-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.0 KB
2025-01-09 00:00
최대주주등소유주식변동신고서
Korean 39.5 KB
2025-01-09 00:00
주식등의대량보유상황보고서(일반)
Korean 99.6 KB
2024-12-27 00:00
횡령ㆍ배임혐의발생
Korean 9.3 KB
2024-12-27 00:00
매매거래정지및정지해제(풍문등조회공시)
Korean 5.3 KB
2024-12-18 00:00
가족친화인증ㆍ유효기간연장ㆍ인증취소(자율공시)
Korean 6.9 KB
2024-12-16 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 6.1 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 3.9 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 864.4 KB

Automate Your Workflow. Get a real-time feed of all KYONGBO PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KYONGBO PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KYONGBO PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.